|
|
Article: FDA Meeting on Antidepressants, Suicidal Thoughts and Behaviors ; Statement by David Shern, Ph.D., President and CEO of Mental Health America
- Article from:
- U.S. Newswire
- Article date:
- December 13, 2006
CopyrightCopyright 2006 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: National Desk, Health Reporter
Contact: Heather Cobb of Mental Health America, 703-797-2588 or
hcobb@mentalhealthamerica.net
ALEXANDRIA, Va., Dec. 13 /U.S. Newswire/ -- Following is a
statement by David Shern, Ph.D., president and CEO of Mental Health
America:
Mental Health America, the country's leading nonprofit advocacy
organization, appreciates the U.S. Food and Drug Administration's
review of suicidality data for various antidepressant drugs in adults
living with depression and other mental disorders. Above all else,
people's safety is paramount. It is important, however, to emphasize
the inherent risk of untreated depression.
Without treatment, this disorder can be fatal - 15 ...